Almac Expands ‘Direct to Patient’ Service to Europe

Almac announced the expansion of its “Direct to Patient” shipping service for clinical trials to EU countries. The Direct to Patient offering is a home delivery service that coordinates all clinical trial (including temperature and non-temperature controlled) material shipments from clinical sites directly to patient’s homes. The expansion to the EU follows the service’s introduction throughout the US and Canada in October 2014.

Read the full release here.